Apollomics corrects director's option expiration date

The director's option vests in two 50% installments, each subject to continued service through its applicable vesting date.

Available on EDGAR 09/24/2026 - 07:50 PM EDT Accepted by SEC EDGAR 09/24/2026 - 07:49 PM EDT Learn about SEC filing dates

This filing corrects an earlier one, and you can read the original Form 4 if you want to see what changed.

Rhea-AI Filing Summary

Apollomics Inc. director Yen Hung Hsien’s transactions include 500 restricted stock units that vested on September 15, 2026, with 500 Class A ordinary shares acquired. On September 14, 2026, Hsien was granted 2,000 stock options with a $23.18 exercise price and a September 14, 2036 expiration date; the amendment corrects the option’s expiration date. The options vest 50% on March 14, 2027, and 50% on September 14, 2027, subject to continued service through each date.

Insider Trade Summary

500 shares exercised/converted

Exercise 3 txns

Insider Yen Hung Hsien

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F1, F3	500	$0.00	$0.00
Exercise	CLASS A ORDINARY SHARES	500	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy) F2	2,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 2,000 contracts (Direct); Restricted Stock Units — 500 contracts (Direct); CLASS A ORDINARY SHARES — 500 shares (Direct)

Holdings Before and After: Stock Option (Right to Buy), 0 to 2,000 contracts (Direct); Restricted Stock Units, 1,000 to 500 contracts (Direct); CLASS A ORDINARY SHARES, 0 to 500 shares (Direct)

Footnotes (3)

1. F1. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share
2. F2. The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.
3. F3. RSUs were granted and previously reported on a Form 3 filed July 24, 2026. The initial RSU grant of 500 shares vested on September 15, 2026.

Key Figures

Restricted stock units vested: 500 units Class A ordinary shares acquired: 500 shares Stock options granted: 2,000 options +2 more

5 metrics

Restricted stock units vested 500 units September 15, 2026

Class A ordinary shares acquired 500 shares Following the September 15, 2026 transaction

Stock options granted 2,000 options Granted September 14, 2026; expiration date September 14, 2036

Exercise price $23.18 per share Stock option granted September 14, 2026

Option vesting installments 50% per installment March 14, 2027, and September 14, 2027; subject to continued service

Key Terms

Restricted Stock Units, exercisable, 2023 Incentive Award Plan

3 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

exercisable financial

"vests and becomes exercisable over a one-year period"

2023 Incentive Award Plan financial

"granted under the Apollomics Inc. 2023 Incentive Award Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Apollomics director Yen Hung Hsien report?

Yen Hung Hsien reported 500 restricted stock units vesting on September 15, 2026, with 500 Class A ordinary shares acquired, and a grant of 2,000 stock options on September 14, 2026.

How do Yen Hung Hsien’s Apollomics stock options vest?

The 2,000 options vest in two 50% installments: one on March 14, 2027, and the other on September 14, 2027, subject to Hsien’s continued service through each applicable vesting date.

Was a Rule 10b5-1 plan reported for Yen Hung Hsien’s Apollomics transactions?

No Rule 10b5-1 plan is reported for these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yen Hung Hsien

(Last) (First) (Middle)

668 ARROW GRAND CIR. SUITE 206

(Street)

COVINA CALIFORNIA 91772

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Apollomics Inc. [ APLM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/17/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
CLASS A ORDINARY SHARES	09/15/2026		M		500	A	$0	500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$23.18	09/14/2026		A		2,000		(2)	09/14/2036	CLASS A ORDINARY SHARES	2,000	$0	2,000	D
Restricted Stock Units	(1)	09/15/2026		M			500	(3)	(3)	CLASS A ORDINARY SHARES	500	$0	500	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share

2. The stock option was granted under the Apollomics Inc. 2023 Incentive Award Plan on September 14, 2026. The option vests and becomes exercisable over a one-year period: fifty percent (50%) of the shares subject to the option vest on March 14, 2027 (six months from the grant date), and the remaining fifty percent (50%) vest on September 14, 2027 (twelve months from the grant date), subject to the reporting person's continued service to the Issuer through each applicable vesting date.

3. RSUs were granted and previously reported on a Form 3 filed July 24, 2026. The initial RSU grant of 500 shares vested on September 15, 2026.

Remarks:

This Form 4 is being amended to correct the expiration date of the stock option.

	/s/ Alison M. Pear, Attorney-In-Fact	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)